Real world treatment patterns of previously treated advanced gastric and gastroesophageal junction adenocarcinoma (GC) in Mexico.

被引：0
|
作者：
Jones, Kyla
Alejandro Silva, Juan
Novick, Diego
Botello, Brenda S.
Monroy Cruz, Barbara
Iglesias-Chiesa, Jm
Quintana, Miguel
机构：
[1] TI Salud, Mexico City, DF, Mexico
[2] Ctr Med Nacl Siglo XXI, Mexico City, DF, Mexico
[3] Eli Lilly & Co, Windlesham, Surrey, England
[4] Eli Lilly & Co, Mexico City, DF, Mexico
[5] Zeed Pharmaceut Solut, Mexico City, DF, Mexico
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.143
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
143
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world treatment patterns of previously treated advanced gastric and gastroesophageal junction adenocarcinoma (GC) in France
    Brown, J.
    Liepa, A.
    Bapat, B.
    Sleilaty, G.
    Kaye, J.
    ANNALS OF ONCOLOGY, 2015, 26
  • [2] Real-world treatment patterns of previously treated advanced gastric and gastroesophageal junction adenocarcinoma (GC) in the United Kingdom (UK).
    Liepa, Astra M.
    Brown, Jacqueline
    Bapat, Bela
    Kaye, James A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [3] Treatment patterns and outcomes in advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in China
    Zhang, Jingdong
    Wang, Guangyu
    Xie, Xianhe
    Pan, Wensheng
    Dong, Qian
    Zhang, Nianhai
    Dong, Jie
    Zhou, Li
    Zhou, Chan
    Li, Jinnan
    Segall, Grace
    Zhang, Yanqiao
    FUTURE ONCOLOGY, 2025,
  • [4] Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma
    Joshi, Smita S.
    Maron, Steven B.
    Catenacci, Daniel V.
    FUTURE ONCOLOGY, 2018, 14 (05) : 417 - 430
  • [5] Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma (aHCC) and previously treated gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJ): Results of the COSMIC-021 study
    Li, D.
    Loriot, Y.
    Burgoyne, A.
    Cleary, J.
    Santoro, A.
    Lin, D.
    Aix, S. Ponce
    Garrido-Laguna, I.
    Sudhagoni, R.
    Lougheed, J.
    Andrianova, S.
    Paulson, S.
    ANNALS OF ONCOLOGY, 2022, 33 : S241 - S241
  • [6] Treatment patterns and clinical outcomes of patients with unresectable advanced or metastatic (UAM) gastric/gastroesophageal junction adenocarcinoma (GA/GEJA) in China: A multicenter real-world study
    Zhang, Y.
    Zhang, J.
    Xie, X.
    Pan, W.
    Wang, G.
    Dong, Q.
    Zhang, N.
    Dong, J.
    Segall, G.
    Zhou, L.
    Zhou, C.
    Khanal, M.
    Yang, Y.
    Zeng, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S1551 - S1551
  • [7] Positioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinoma
    Pericay, Carles
    Rivera, Fernando
    Gomez-Martin, Carlos
    Nunez, Inmaculada
    Cassinello, Alejo
    Rodrigo Imedio, Esteban
    CANCER MEDICINE, 2016, 5 (12): : 3464 - 3474
  • [8] Real-world comparison of treatment outcomes between advanced esophagogastric junction adenocarcinoma and gastric adenocarcinoma.
    Kadono, Toru
    Hirose, Toshiharu
    Hirano, Hidekazu
    Shoji, Hirokazu
    Okita, Natsuko Tsuda
    Takashima, Atsuo
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 267 - 267
  • [9] Real-world biomarker testing patterns, first line treatment and drivers of treatment choice in patients with advanced/metastatic gastric/gastroesophageal junction adenocarcinoma in the United States and Europe.
    Lordick, Florian
    Starling, Naureen
    Ajani, Jaffer A.
    Gu, Jin
    Koralek, Daniel O.
    Mhatre, Shivani K.
    Hogea, Cosmina
    Hammond, Chloe
    Lewis, Katie
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 353 - 353
  • [10] Real-world Treatment Patterns and Clinical Outcomes Across Lines of Therapy in Patients With Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer
    Le, Dung T.
    Ott, Patrick A.
    Korytowsky, Beata
    Le, Hannah
    Le, T. Kim
    Zhang, Ying
    Maglinte, Gregory A.
    Abraham, Pranav
    Patel, Dhiren
    Shangguan, Tong
    Chau, Ian
    CLINICAL COLORECTAL CANCER, 2020, 19 (01) : 32 - +
12345